NDC 50090-7236-00 - Ezetimibe
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7236
- Requested NDC
- 50090-7236-00
- Package NDCs from labels
- 50090-7236-0, 50090-7236-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-10-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ezetimibe - A-S Medication Solutions | A-S Medication Solutions | 2025-10-10 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7236-0 | Ezetimibe | 90 in 1 BOTTLE | TABLET | 90 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | KC Pharmaceuticals, Inc | 4de5c844-85ca-ff9f-e063-6394a90ac12c | 2026-03-25 | Warnings | 3NXW29V3WO |
| EZETIMIBE | EZETIMIBE | Bryant Ranch Prepack | 02b00cb2-7253-4fb4-a216-53691a929a28 | 2026-02-17 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | A-S Medication Solutions | 2ce219a2-1eeb-4ece-bb87-3810e593ca51 | 2026-02-06 | Warnings, Adverse reactions | EOR26LQQ24 |
| VYTORIN | EZETIMIBE AND SIMVASTATIN | Organon LLC | 89b860d2-de83-468e-b7e8-76aeec2edca2 | 2026-01-21 | Warnings, Adverse reactions | EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | AvPAK | 6fcbfbd9-6e09-8224-e053-2a91aa0a8226 | 2026-01-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Discount Drug Mart Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Discount Drug Mart | f7fd53be-e501-d97f-e053-6394a90ad409 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Exchange Select Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Army and Air Force Exchange Service | 9e478343-8ae7-823e-e053-2995a90a84ed | 2025-12-30 | Warnings | 3NXW29V3WO |
| DG Health Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYPROPYLENE GLYCOL 400 | Dolgencorp LLC | 9cb20c3b-bf6d-8c7c-e053-2995a90aa485 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Core Values Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Liberty Procurement Co. Inc. | f8285f68-c40c-19a8-e053-6394a90aacad | 2025-12-30 | Warnings | 3NXW29V3WO |
| Harris Teeter Eye Drops Artificial Tears | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Harris Teeter, LLC. | f82957d9-c4ad-a914-e053-6294a90aac50 | 2025-12-30 | Warnings | 3NXW29V3WO |
| CVS Gentle Tears | DEXTRAN 70, HYPROMELLOSE | CVS Pharmacy, Inc. | 9b1ea0eb-c34f-6603-e053-2995a90a6a95 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Artificial Tears | GLYCERIN | Geri-Care Pharmaceuticals, Corp | 7cc437e3-bad9-59be-e053-2991aa0a1da3 | 2025-12-19 | Warnings | 3NXW29V3WO |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | 3NXW29V3WO |
| Zetia | EZETIMIBE | Organon LLC | 174e45e0-45bb-48b7-9e60-8f6cfc1d22bb | 2025-11-25 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Golden State Medical Supply, Inc. | 88cd0e7b-e8dc-6125-e053-2a95a90aaa27 | 2025-11-24 | Warnings, Adverse reactions | EOR26LQQ24 |
| EZETIMIBE | EZETIMIBE | Accord Healthcare Inc. | ceecdbe9-5404-4a93-a488-9211cd103058 | 2025-10-14 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | American Health Packaging | 0e9a9eda-1b2a-4475-8483-0f410a17c524 | 2025-10-14 | Warnings, Adverse reactions | ANDA209234 349556 EOR26LQQ24 |
| EZETIMIBE | EZETIMIBE | A-S Medication Solutions | 4cfda5aa-e21a-47b2-b296-88d8336298ef | 2025-10-14 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| EZETIMIBE | EZETIMIBE | A-S Medication Solutions | 4158aa71-3540-4912-b909-7491e5a1429c | 2025-10-14 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | dd8a09cb-f014-4650-9da2-4ad1581c9741 | 2025-10-10 | Warnings, Adverse reactions | ANDA209234 50090-7236-0 50090-7236 50090723600 349556 6d15d418-3f41-4aca-aafb-a331a85df702 dd8a09cb-f014-4650-9da2-4ad1581c9741 EOR26LQQ24 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.